日报更新时间：
周报更新时间：04-11 03:39
今开价：499.82
最高价：509.97
成交量：433352.0
昨收价：502.88
最低价：498.13
最新价：506.43
中文名称：IDEXX实验室
英文名称：IDEXX Laboratories
行业：医疗
简介：IDEXX Laboratories, Inc.位于特拉华州，于1983年注册
电话：1-207-5560300
美国爱德士生物科技公司（爱德士实验室公司）在动物健康、水和牛奶质量检测领域，是诊断和信息技术解决方案的全球领导者，在全球60多个地区进行运营。IDEXX Laboratories最大的业务部门帮助全球范围内50000多个宠物诊所推进医疗护理，提高员工生产力，增加诊所盈利。爱德士通过一个完整的诊断服务组合来实现，该组合包括宠物现场诊断，定点医护设备，参考实验室服务，数字放射技术和诊所管理方案。此外，爱德士是确保水质安全的微生物检测技术的全球领先者；也是确保乳品安全和经济动物健康的诊断试剂和健康监测体系的顶级供应商。爱德士实验室公司分为5个部门来运作：宠物集团（Companion Animal Group）、水质产品（Water Quality Products）、家畜（Livestock）、家禽和奶制品（Poultry and Dairy）以及其他部门（Other）。IDEXX Laboratories公司提供： 医护站兽医诊断产品，包括：仪器、耗材、快速检测、兽医参考实验室诊断和咨询服务。 执业管理系统和服务，以及提供给兽医的数字影像系统和生物材料测试，与供应医学研究社群的实验室动物的生物诊断工具和服务。 针对家畜、家禽和奶制品提供诊断，健康监测和食品安全检测产品。 提供测试水质中某些微生物污染物的产品与在医护点照护的电解质和被使用在人类在医护点照护的医学诊断市场上的血液气体分析仪。爱德士实验室 IDEXX Laboratories(IDXX)收购历史： 2011年11月，收购密苏里大学（University of Missouri）兽医学院（College of Veterinary Medicine）的研究和诊断实验室； 2013年8月，收购Madasa do Brasil Ltda。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-07-29 | Vandebroek (Sophie V) | Director | Buy | 70 | 286.05 |
| 2019-07-29 | Junius (Daniel M) | Director | Buy | 22 | 286.05 |
| 2019-07-29 | Essig (Stuart M) | Director | Buy | 70 | 286.05 |
| 2019-05-31 | Turner (Kathy V) | Officer | Buy | 466 | -- |
| 2019-05-31 | Turner (Kathy V) | Officer | Sell | 118 | 249.77 |
| 2019-05-30 | Twigge Giovani | Officer | Sell | 2600 | 250.14 |
| 2019-05-12 | Henderson (Rebecca M) | Director | Sell | 8790 | 241.57 |
| 2019-05-12 | Henderson (Rebecca M) | Director | Buy | 8790 | 43.68 |
| 2019-05-09 | Lane (Michael J) | Officer | Sell | 1812 | 245.41 |
| 2019-05-05 | Twigge Giovani | Officer | Sell | 2015 | 250.00 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 629 | 248.79 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 375 | 245.77 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Buy | 7504 | 44.05 |
| 2019-05-02 | Ayers (Jonathan W) | Chief Executive Officer | Sell | 11400 | 248.57 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 225 | 247.28 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 204 | 242.72 |
| 2019-05-02 | Ayers (Jonathan W) | Chief Executive Officer | Sell | 2600 | 247.81 |
| 2019-05-02 | Ayers (Jonathan W) | Chief Executive Officer | Buy | 28000 | 45.84 |
| 2019-05-02 | Ayers (Jonathan W) | Chief Executive Officer | Sell | 13900 | 249.62 |
| 2019-05-02 | Ayers (Jonathan W) | Chief Executive Officer | Sell | 100 | 250.02 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 300 | 244.57 |
| 2019-05-02 | McKeon (Brian P) | Chief Financial Officer | Sell | 5771 | 248.28 |
| 2019-04-29 | Essig (Stuart M) | Director | Buy | 81 | 232.00 |
| 2019-04-29 | Junius (Daniel M) | Director | Buy | 26 | 232.00 |
| 2019-04-29 | Vandebroek (Sophie V) | Director | Buy | 81 | 232.00 |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Capital World Investors | 1082373 | 1.26% | 7838 | 0.73% | 2019-03-31 |
| BlackRock Fund Advisors | 2393022 | 2.78% | -1910946 | -44.40% | 2019-07-31 |
| T. Rowe Price Associates, Inc. | 2392988 | 2.78% | 21096 | 0.89% | 2019-03-31 |
| Vanguard Investments Australia Ltd | 2403386 | 2.79% | 348 | 0.01% | 2019-07-31 |
| State Street Corporation | 3705170 | 4.31% | 132083 | 3.70% | 2019-03-31 |
| BAMCO Inc | 4016927 | 4.67% | -114303 | -2.77% | 2019-03-31 |
| Fundsmith LLP | 4467341 | 5.19% | 35049 | 0.79% | 2019-03-31 |
| BlackRock Inc | 6511387 | 7.57% | -37635 | -0.57% | 2019-03-31 |
| Vanguard Group Inc | 9135240 | 10.62% | 78089 | 0.86% | 2019-03-31 |
| Blair William & Co | 1582222 | 1.84% | 10586 | 0.67% | 2019-03-31 |
| Neuberger Berman Group LLC | 1500543 | 1.74% | -11175 | -0.74% | 2019-03-31 |
| Neuberger Berman Investment Advisers LLC | 1500543 | 1.74% | -11175 | -0.74% | 2019-03-31 |
| American Century Companies Inc | 1483074 | 1.72% | 780846 | 111.20% | 2019-03-31 |
| Ameriprise Financial Inc | 1472954 | 1.71% | -62508 | -4.07% | 2019-03-31 |
| Columbia Mgmt Investment Advisers, LLC | 1446097 | 1.68% | -68693 | -4.53% | 2019-03-31 |
| State Street Global Advisors | 1429626 | 1.66% | -2509 | -0.18% | 2019-07-31 |
| Geode Capital Management, LLC | 1377665 | 1.60% | -948153 | -40.77% | 2019-03-31 |
| Putnam Investment Management, LLC | 1117385 | 1.30% | 431185 | 62.84% | 2019-07-31 |
| Baron Capital Management Inc | 1100000 | 1.28% | -5000 | -0.45% | 2019-07-31 |
| Renaissance Technologies Corp | 1089125 | 1.27% | -427204 | -28.17% | 2019-03-31 |
| Amvescap Plc. | 1132417 | 1.32% | -102611 | -8.31% | 2018-12-31 |
| BlackRock Asset Management Canada Ltd | 2685709 | 3.12% | 3784 | 0.14% | 2019-05-31 |
| BlackRock Japan Co Ltd | 1262644 | 1.47% | 1144 | 0.09% | 2019-05-31 |
| Goldman Sachs Asset Management, L.P. | 1338529 | 1.56% | -4054 | -0.30% | 2018-12-31 |
| Goldman Sachs Group Inc | 1532835 | 1.78% | -43841 | -2.78% | 2018-12-31 |
| Invesco Capital Management LLC | 1083144 | 1.26% | -62020 | -5.42% | 2019-03-31 |
| Bank of New York Mellon Corp | 1082526 | 1.26% | -22161 | -2.01% | 2018-09-30 |
| Fundsmith Equity Fund, L.P. | 4429104 | 5.14% | 4429104 | -- | 2018-06-30 |
| Capital Research and Management Company | 1059793 | 1.23% | 1669 | 0.16% | 2018-11-30 |
| BlackRock Institutional Trust Company NA | 2219873 | 2.57% | -497707 | -18.31% | 2018-06-30 |
| Neuberger Berman LLC | 1615073 | 1.87% | -35797 | -2.17% | 2018-03-31 |
| State Street Corp | 3426982 | 3.96% | -79800 | -2.28% | 2018-06-30 |
| Baron Capital Group | 4700932 | 5.40% | -989955 | -17.40% | 2017-12-31 |
| Columbia Mangmt Investment Advisers, LLC | 1609453 | 1.86% | -75826 | -4.50% | 2018-06-30 |
| Invesco PowerShares Capital Mgmt LLC | 1116313 | 1.29% | 404315 | 56.79% | 2018-06-30 |
| State Street Global Advisors (Aus) Ltd | 1001209 | 1.16% | 23817 | 2.44% | 2018-09-12 |
| Northern Trust Investments N A | 1039797 | 1.20% | 33222 | 3.30% | 2018-06-30 |
| Arrowstreet Capital Limited Partnership | 1009333 | 1.16% | -65656 | -6.11% | 2018-06-30 |
| Goldman Sachs Asset Management LP | 983201 | 1.13% | 659847 | 204.06% | 2018-06-30 |
| Old Mutual Asset Managers UK Ltd | 927868 | 1.07% | -6302 | -0.67% | 2018-06-30 |
| American Century Inv Mgt Inc | 884600 | 1.02% | -61791 | -6.53% | 2018-03-31 |
| HHG PLC | 889936 | 1.02% | -172549 | -16.24% | 2017-12-31 |
| NORGES BANK | 801237 | 0.92% | -154994 | -16.21% | 2017-12-31 |
| Capital Counsel LLC | 733063 | 0.84% | -2775 | -0.38% | 2017-09-30 |
| Goldman, Sachs & Co. | 771760 | 0.88% | 234410 | 43.62% | 2017-06-30 |
| Atlanta Capital Management Company,LLC | 2231311 | 2.49% | -274206 | -10.94% | 2016-09-30 |
| Select Equity Group LP | 2184013 | 2.43% | -723904 | -24.89% | 2016-09-30 |
| William Blair Investment Management, LLC | 1711947 | 1.91% | -221047 | -11.44% | 2016-09-30 |
| Federated Global Inv Mgmt Corp | 1146700 | 1.28% | -41990 | -3.53% | 2016-09-30 |
| State Street Global Markets, LLC | 1036715 | 1.16% | 28616 | 2.84% | 2016-12-31 |
| J.P. Morgan Investment Management Inc | 1003596 | 1.12% | -131893 | -11.62% | 2016-09-30 |
| Brown Investment Advisory Incorporated | 716740 | 0.80% | -40952 | -5.40% | 2016-09-30 |
| Royce & Associates, LLC | 708990 | 0.79% | -154822 | -17.92% | 2016-09-30 |
| William Blair& Company, LLC | 5605902 | 3.00% | 439586805 | 0.10% | 1999-11-30 |
| The Vanguard Group | 5909806 | 3.00% | 463417437 | 0.10% | 1999-11-30 |
| BlackRock, Inc. | 6184490 | 3.00% | 484956783 | 0.10% | 1999-11-30 |
| Baron Capital Group, Inc. | 7246008 | 3.00% | 568195717 | 0.10% | 1999-11-30 |
| Ruane, Cunniff& Goldfarb Inc. | 8896814 | 3.00% | 697643670 | 0.10% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Vanguard Mid-Cap Growth Index Fund | 547607 | 0.64% | 21642 | 4.11% | 2019-06-30 |
| American Funds New Perspective Fund | 1017000 | 1.18% | -- | -- | 2019-06-30 |
| Baron Small-Cap Growth Strategy-UBS | 1100000 | 1.28% | -5000 | -0.45% | 2019-06-30 |
| Baron Growth Fund | 1100000 | 1.28% | -5000 | -0.45% | 2019-06-30 |
| Vanguard 500 Index Fund | 1691904 | 1.97% | 17408 | 1.04% | 2019-06-30 |
| T. Rowe Price New Horizons Fund | 1710387 | 1.99% | 643300 | 60.29% | 2019-06-30 |
| Vanguard Mid-Cap Index Fund | 2095100 | 2.43% | 28017 | 1.36% | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 2368567 | 2.75% | 346 | 0.01% | 2019-06-30 |
| OMIM FundSmith Equity Feeder | 4242323 | 4.93% | -- | -- | 2019-03-31 |
| Baron Asset Fund | 976630 | 1.13% | -- | -- | 2019-06-30 |
| SPDR | 954128 | 1.11% | 884 | 0.09% | 2019-07-31 |
| Baron Partners Fund | 900000 | 1.05% | -- | -- | 2019-06-30 |
| Vanguard Growth Index Fund | 614563 | 0.71% | 20457 | 3.44% | 2019-06-30 |
| iShares Core S&P 500 ETF | 635203 | 0.74% | -312 | -0.05% | 2019-07-30 |
| Merian Global Equity Absolute Return Fd | 656469 | 0.76% | -940 | -0.14% | 2018-12-31 |
| Principal MidCap Fund | 671379 | 0.78% | -1230 | -0.18% | 2019-06-30 |
| Fidelity | 696466 | 0.81% | 10266 | 1.50% | 2019-06-30 |
| Neuberger Berman Genesis Fund | 755959 | 0.88% | -21800 | -2.80% | 2019-03-31 |
| Invesco QQQ Trust | 772463 | 0.90% | 679 | 0.09% | 2019-07-31 |
| Vanguard Institutional Index Fund | 803077 | 0.93% | -5568 | -0.69% | 2019-06-30 |
| Fundsmith Equity | 4242323 | 4.93% | -- | -- | 2019-03-31 |
| Fundsmith Equity Sicav | 4242323 | 4.93% | -- | -- | 2018-12-31 |
| iShares Core S&P 500 ETF (CAD-Hedged) | 631322 | 0.73% | 572 | 0.09% | 2019-05-30 |
| iShares S&P 500 ETF | 631322 | 0.73% | 572 | 0.09% | 2019-05-30 |
| iShares Core S&P US Total Market ETF | 631322 | 0.73% | 572 | 0.09% | 2019-05-30 |
| Fundsmith Equity Fund Feeder | 4242323 | 4.93% | -- | -- | 2018-12-31 |
| iShares Core MSCI Kokusai ETF | 631322 | 0.73% | 572 | 0.09% | 2019-05-30 |
| iShares MSCI World ETF | 624406 | 0.73% | -1300 | -0.21% | 2019-04-25 |
| Baron Small Cap Fund | 550000 | 0.64% | -25000 | -4.35% | 2018-12-31 |
| Old Mutual Global Eq Abs Ret Fund | 657409 | 0.76% | -60862 | -8.47% | 2018-06-30 |
| VA CollegeAmerica New Perspective Fd | 1017000 | 1.18% | -- | -- | 2018-12-31 |
| OH Putnam Fidelity Spartan 500 Index | 646025 | 0.75% | 18691 | 2.98% | 2019-01-31 |
| Franklin DynaTech Fund | 450000 | 0.52% | -- | -- | 2018-12-31 |
| Health Care Select Sector SPDR | 488009 | 0.57% | 11628 | 2.44% | 2019-01-31 |
| Franklin DynaTech | 450000 | 0.52% | -- | -- | 2018-12-31 |
| Baron Partners Retail | 900000 | 1.04% | -- | -- | 2018-06-30 |
| Vanguard Institutional Index I | 840288 | 0.97% | 1544 | 0.18% | 2018-07-31 |
| VA CollegeAmerica New Perspective 529E | 1017000 | 1.17% | -- | -- | 2018-06-30 |
| Baron Asset Retail | 1067630 | 1.23% | -20000 | -1.84% | 2018-06-30 |
| Baron Growth Retail | 1200000 | 1.39% | -50000 | -4.00% | 2018-06-30 |
| Vanguard 500 Index Inv | 1572454 | 1.82% | 1479 | 0.09% | 2018-07-31 |
| Vanguard Mid Cap Index I | 2060396 | 2.38% | 12062 | 0.59% | 2018-07-31 |
| Vanguard Total Stock Mkt Idx | 2181979 | 2.52% | 5812 | 0.27% | 2018-07-31 |
| Neuberger Berman Genesis Inv | 858104 | 0.99% | -28365 | -3.20% | 2018-06-30 |
| PowerShares QQQ ETF | 711677 | 0.81% | -2760 | -0.39% | 2018-09-13 |
| Columbia Select Large Cap Growth Z | 398516 | 0.46% | -47820 | -10.71% | 2018-07-31 |
| Franklin DynaTech Fund A | 425000 | 0.49% | 25000 | 6.25% | 2018-07-31 |
| American Century Ultra | 546000 | 0.63% | -36000 | -6.19% | 2018-06-30 |
| Vanguard Mid-Cap Growth ETF | 527395 | 0.61% | 2273 | 0.43% | 2018-07-31 |
| Fidelity Spartan | 578611 | 0.67% | 6824 | 1.19% | 2018-07-31 |
| T. Rowe Price New Horizons | 670987 | 0.77% | -60400 | -8.26% | 2018-06-30 |
| Baron Small Cap Retail | 675000 | 0.78% | -25000 | -3.57% | 2018-06-30 |
| Vanguard Growth Index Inv | 611774 | 0.71% | -1777 | -0.29% | 2018-07-31 |
| Federated Kaufmann Large Cap A | 393000 | 0.45% | -- | -- | 2017-12-31 |
| T. Rowe Price Mid-Cap Growth | 350000 | 0.40% | -- | -- | 2017-12-31 |
| Eaton Vance Atlanta Capital SMID-Cap I | 1792425 | 2.00% | -- | -- | 2016-12-31 |
| Vanguard Extended Market Idx Inv | 1060981 | 1.18% | 32154 | 3.13% | 2016-12-31 |
| JPMorgan Small Cap Equity A | 589165 | 0.66% | 30393 | 5.44% | 2016-12-31 |
| Federated Kaufmann R | 500000 | 0.56% | -- | -- | 2016-09-30 |
| Royce Premier Invmt | 382900 | 0.43% | -107000 | -21.84% | 2016-12-31 |
| SPDR® S&P MIDCAP 400 ETF | 942069 | 1.00% | 42909 | 4.80% | 2015-10-31 |
| Vanguard Extended Market Index Fund | 943314 | 1.00% | 9500 | 1.00% | 2015-10-31 |
| Royce Premier Fund | 1084200 | 1.20% | 93400 | 9.40% | 2015-09-30 |
| Eaton Vance Atlanta Capital SMID-Cap Fd | 1414610 | 1.50% | -- | -- | 2015-06-30 |
| iShares Core S&P Mid-Cap (AU) | 1606047 | 1.80% | 864 | -- | 2015-11-27 |
| T. Rowe Price Mid-Cap Growth Fund | 2500000 | 2.70% | -- | -- | 2015-09-30 |
| Sequoia Fund | 3140822 | 3.40% | -- | -- | 2015-06-30 |
| James F. Polewaczyk | James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University. |
|---|---|
| Daniel M. Junius | Currently, Daniel M. Junius is Chief Financial Officer at Deluxepinpoint Co. Mr. Junius is also on the board of IDEXX Laboratories, Inc. and GlycoMimetics, Inc. and Treasurer & Director at Biotechnology Innovation Organization. He previously occupied the position of Director at ImmunoGen, Inc., Chief Financial Officer & Executive Vice President at Deluxe Business Operations, Inc. and Chief Financial Officer & Vice President of Nashua Corp. Daniel M. Junius received an undergraduate degree from Boston College and a graduate degree from Kellogg School of Management. |
| M. Anne Szostak | Founder of Szostak Partners LLC, M. Anne Szostak is a businessperson who has been at the head of 6 different companies and is President & Chief Executive Officer at this company. She is also on the board of 8 other companies. In the past Ms. Szostak was Chairman & Chief Executive Officer for Fleet Bank (Rhode Island), NA, Chairman, President & Chief Executive Officer of Fleet Maine, NA, EVP, Director-Human Resources & Diversity at FleetBoston Financial Corp., Chairman of Women & Infants Corp. and Chairman for Women & Infants Hospital of Rhode Island. M. Anne Szostak received an undergraduate degree from Colby College. |
| Rebecca M. Henderson | Rebecca M. Henderson is on the board of Amgen, Inc., IDEXX Laboratories, Inc. and Business & Environment Initiative and Associate at National Bureau of Economic Research, Inc., Co-Director-Business Environment Initiative at Harvard Business School and Professor at Harvard University. In her past career Rebecca M. Henderson was Professor at MIT Sloan School of Management and Professor at Massachusetts Institute of Technology. Dr. Henderson received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard University. |
| Lawrence D. Kingsley | Lawrence D. Kingsley is on the board of Microfluidics International Corp. and 4 other companies. In the past Mr. Kingsley held the position of Non-Executive Chairman for IDEX Corp., President at The Motion Group of Cos., Inc., VP, Group Executive-Sensors & Controls Business at Danaher Corp. and Chairman & Chief Executive Officer for Pall Corp. (a subsidiary of Danaher Corp.), GM-Industrial & Commercial Products Division at Kollmorgen Corp. and Principal at W Interconnections, Inc. Lawrence D. Kingsley received an undergraduate degree from Clarkson University and an MBA from The College of William & Mary. |
| James F. Polewaczyk | James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University. |
| James F. Polewaczyk | James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University. |
| Giovani Twigge | Giovani Twigge is Chief Human Resources Officer & Vice President at IDEXX Laboratories, Inc. In his past career he occupied the position of Divisional Vice President-Human Resources at Abbott Nutrition Manufacturing, Inc. and Divisional Vice President-Human Resources at Abbott Diagnostics, Inc. Mr. Twigge received an undergraduate degree from the University of Pretoria. |
| George J. Fennell | Currently, George J. Fennell occupies the position of Vice President at IDEXX Laboratories, Inc. In the past he was Vice President-Animal Genetics & Diagnostics at Zoetis, Inc., Business Director at Wyeth Holdings LLC and Manager-Product Marketing Strategy at BASF Corp. Mr. Fennell received an undergraduate degree from the University of Delaware. |
| Bruce L. Claflin | Bruce L. Claflin founded Kids First (Virgin Islands). He is on the board of IDEXX Laboratories, Inc. and Ciena Corp. and President & Director at Kids First (Virgin Islands). In the past Mr. Claflin was Independent Director at Advanced Micro Devices, Inc., General Manager-Products & Brand Management at International Business Machines Corp. and President for IBM PC Co. (a subsidiary of International Business Machines Corp.), President, Chief Executive Officer & Director at 3Com Corp., President for 3Com Ventures, Inc. and Senior Vice President-Sales & Marketing for Digital Equipment Corp. Mr. Claflin received an undergraduate degree from The Pennsylvania State University. |
| Stuart M. Essig | Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology. |
| Rebecca M. Henderson | Rebecca M. Henderson is on the board of Amgen, Inc., IDEXX Laboratories, Inc. and Business & Environment Initiative and Associate at National Bureau of Economic Research, Inc., Co-Director-Business Environment Initiative at Harvard Business School and Professor at Harvard University. In her past career Rebecca M. Henderson was Professor at MIT Sloan School of Management and Professor at Massachusetts Institute of Technology. Dr. Henderson received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard University. |
| Brian Patrick McKeon | Currently, Brian Patrick McKeon is Chief Financial Officer, Treasurer & Executive VP of IDEXX Laboratories, Inc. and Chief Financial Officer for Iron Mountain Information Management, Inc. He is also on the board of IDEXX Laboratories Ltd. and IDEXX UK Acquisition Ltd. In his past career Mr. McKeon held the position of Manager-Strategic Planning at PepsiCo, Inc. and Vice President-Finance at Pepsi-Cola North America (a subsidiary of PepsiCo, Inc.), Senior VP-Worldwide Consulting Services at J.D. Edwards, Inc., VP-Delivery & Center Project Performance at CMTSU Liquidation, Inc., Chief Financial Officer & Executive Vice President at Iron Mountain, Inc., Chief Financial Officer & EVP-Administration at Timberland LLC, Chief Financial Officer & Senior Vice President for Amazon.com LLC and Auditor for Coopers & Lybrand LLP. Brian Patrick McKeon received an undergraduate degree from the University of Connecticut and an MBA from Harvard University. |
| Sophie V. Vandebroek | Sophie V. Vandebroek is on the board of IDEXX Laboratories, Inc. and Worcester Polytechnic Institute and Member of Women in Technology International, Member of Koninklijke Vlaamse Academie van Belgi�0�1�0�0 voor Wetenschappen en and Vice President-Emerging Technology Partnerships at International Business Machines Corp. She previously was CTO & President-Xerox Innovation Group at Xerox Corp. and Vice President at Xerox Engineering Center (a subsidiary of Xerox Corp.) and Chief Technology Officer for Carrier Corp. Dr. Vandebroek received a doctorate from Cornell University and a graduate degree and an undergraduate degree from Katholieke Universiteit Leuven. |
| Daniel M. Junius | Currently, Daniel M. Junius is Chief Financial Officer at Deluxepinpoint Co. Mr. Junius is also on the board of IDEXX Laboratories, Inc. and GlycoMimetics, Inc. and Treasurer & Director at Biotechnology Innovation Organization. He previously occupied the position of Director at ImmunoGen, Inc., Chief Financial Officer & Executive Vice President at Deluxe Business Operations, Inc. and Chief Financial Officer & Vice President of Nashua Corp. Daniel M. Junius received an undergraduate degree from Boston College and a graduate degree from Kellogg School of Management. |
| Jonathan J. Mazelsky | Jonathan J. Mazelsky is President, Chief Executive Officer & Executive VP at IDEXX Laboratories, Inc. In the past Mr. Mazelsky held the position of General Manager for Agilent Technologies, Inc. and SVP, GM-Computed Tomography & Nuclear Medicine at Philips Medical Systems (Cleveland), Inc. He received an undergraduate degree from the University of Rochester and an MBA from The University of Chicago. |
| Sharon E. Underberg | Currently, Sharon E. Underberg occupies the position of Secretary, Vice President & General Counsel for IDEXX Laboratories, Inc. In the past Ms. Underberg occupied the position of Secretary, Senior Vice President & General Counsel for Eastman Kodak Co. and Attorney at Norton Rose Fulbright US LLP. Ms. Underberg received an undergraduate degree from Brandeis University and a graduate degree from The University of Pennsylvania Law School. |
| Pat Venters | Currently, Pat Venters is Chief Marketing Officer & Vice President at IDEXX Laboratories, Inc. |
| Sam A. Samad | Mr. Sam A. Samad is an Independent Director at IDEXX Laboratories, Inc. and a Chief Financial Officer & Senior Vice President at Illumina, Inc. He is on the Board of Directors at IDEXX Laboratories, Inc. Mr. Samad was previously employed as a Treasurer & Senior Vice President by Cardinal Health, Inc. He received his undergraduate degree from American University of Beirut and an MBA from McMaster University. |
| Ken Grady | Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology. |
| Ken Grady | Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology. |
| Jeffrey Thomas | Currently, Jeffrey Thomas occupies the position of Chief Technology Officer & Vice President at IDEXX Laboratories, Inc. He previously was Director-Research & Development at Dako Corp. He received an undergraduate degree from the University of Utah and an MBA from MIT Sloan School of Management. |
| Kathy V. Turner | Kathy V. Turner is Corporate Vice President at IDEXX Laboratories, Inc. |
| Michael Lane | Michael Lane is Vice President at IDEXX Laboratories, Inc. |
| Tina Hunt | Tina Hunt is Corporate Vice President at IDEXX Laboratories, Inc. |
| John Ravis | Presently, John Ravis holds the position of Head-Investor relations of IDEXX Laboratories, Inc. |
| John Hart | John Hart is Vice President-Worldwide Operations at IDEXX Laboratories, Inc. Mr. Hart received an undergraduate degree from Bowdoin College and an MBA from New York University. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论